Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying
The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?
Feb 21, 2022 02:30 PM
Global Auto Chip Shortage: Challenges, Opportunities and Implications for OEMs
ResearchHealthcare, Consumer Staples, Technology
WIA2020 | Rising Tech Stars 2020: Global & China's 100